Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GYRE — GYRE THERAPEUTICS, INC. SEC Filings | FilingIndex

GYRENasdaq

GYRE THERAPEUTICS, INC.

Pharmaceutical Preparations · DE · CIK 1124105

Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases

red 8-K · 90d

+ Watch View on EDGAR ↗

$575M

Market cap

$6.59

Last close

+2.2%

1D

+7.5%

5D

61K

Volume

Price · last 40 sessions-16.8%

May 4L $5.56 · H $8.04Jun 30

386

Total filings

Jun 16, 2026

Last filing

12/31

Fiscal year end

All 8-K · 212 10-Q · 40 SC 13G · 34 DEFA14A · 26 424B5 · 14 10-K · 13 SC 13D · 12 DEF 14A · 12

10-K10-KMar 13, 2026 10-K10-KMar 17, 2025 10-K10-KMar 27, 2024 10-K10-KMar 30, 2023 10-K10-KMar 31, 2022 10-K

Similar companies

Comparable business profile · signals at a glance

CTNMContineum Therapeutics, Inc.$444.2M+9.3%ZLABZai Lab Ltd$1.9B+3.2%SIONSionna Therapeutics, Inc.$1.6B+2.4%RNTXRein Therapeutics, Inc.$81.9M0.0%MDGLMADRIGAL PHARMACEUTICALS, INC.

10-K

Mar 4, 2021

10-K10-KFeb 20, 2020

10-K10-KMar 8, 2019

10-K10-KMar 19, 2018

10-K10-KMar 8, 2017

10-KFORM 10-KMar 9, 2016

10-K10-KMar 16, 2015

10-K10-KMar 14, 2014

$11.1B

+1.8%

KROSKeros Therapeutics, Inc.$200.9M-2.1%